This brand name is authorized in Austria, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia
The drug SOLUVIT contains a combination of these active pharmaceutical ingredients (APIs):
1
Vitamin B1
UNII 8K0I04919X - THIAMINE MONONITRATE
|
Thiamine pyrophosphate (TPP), the coenzymatic form of thiamine, is involved in two main types of metabolic reactions: decarboxylation of α-ketoacids (e.g. pyruvate, α-ketoglutarate and branched-chain keto acids) and transketolation (e.g. among hexose and pentose phosphates). Therefore, the principal physiological role of thiamine is as a coenzyme in carbohydrate metabolism, where TPP is required for several stages in the breakdown of glucose to provide energy. |
2
Riboflavin
UNII 20RD1DZH99 - RIBOFLAVIN 5'-PHOSPHATE SODIUM DIHYDRATE
|
Riboflavine is phosphorylated to flavine mononucleotide and flavine adenine dinucleotide which act as co-enzymes in the respiratory chain and in oxidative phosphorylation. Riboflavine deficiency presents with ocular symptoms, as well as lesions on the lips and at angles of the mouth. |
3
Niacinamide
UNII 25X51I8RD4 - NIACINAMIDE
|
|
4
Pyridoxine
UNII 68Y4CF58BV - PYRIDOXINE HYDROCHLORIDE
|
Pyridoxine hydrochloride is Vitamin B6. It is converted to pyridoxal phosphate which is the co-enzyme for a variety of metabolic transformations. It is essential for human nutrition. |
5
Pantothenic acid
UNII OES0R93F0C - SODIUM PANTOTHENATE
|
Pantothenic acid is incorporated into co-enzyme A and is involved in metabolic pathways involving acetylation which includes detoxification of drug molecules and biosynthesis of cholesterol, steroid hormones, mucopolysaccharides and acetylcholine. CoA has an essential function in lipid metabolism. |
6
Vitamin C
UNII S033EH8359 - SODIUM ASCORBATE
|
Ascorbic acid, coupled with dehydroascorbic acid to which it is reversibly oxidised, has a variety of functions in cellular oxidation processes. Ascorbic acid is required in several important hydroxylations, including the conversion of proline to hydroxyproline and appears to have an important role in metal ion metabolism, including the gastrointestinal absorption of iron and its transport between plasma and storage organs. |
7
Biotin
UNII 6SO6U10H04 - BIOTIN
|
Biotin is a co-enzyme for carboxylation during the metabolism of proteins and carbohydrates. |
8
Folic acid
UNII 935E97BOY8 - FOLIC ACID
|
Folic acid is a member of the vitamin B group which is reduced in the body to tetrahydrofolate, a co-enzyme active in several metabolic processes and produces a haemopoietic response in nutritional megaloblastic anaemias. Folic acid is rapidly absorbed and widely distributed in body tissues. |
9
Vitamin B12
UNII P6YC3EG204 - CYANOCOBALAMIN
|
Hydroxocobalamin is used in the treatment and prevention of Vitamin B12 deficiency. For adults, the daily requirement of Vitamin B12 is probably about 1 to 2 micrograms and this amount is present in most normal diets. However, Vitamin B12 only occurs in animal products, not in vegetables, and therefore strict vegetarian or vegan diets that exclude dairy products may provide an inadequate amount, although a deficiency may not be apparent for many years. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
A11BA | Multivitamins, plain | A Alimentary tract and metabolism → A11 Vitamins → A11B Multivitamins, plain |
B05XC | Vitamins | B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05X I.V. solution additives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): H7611013 |
Country: EE | Ravimiamet | Identifier(s): 1101362 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 61228 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 191254 |
Country: FR | Base de données publique des médicaments | Identifier(s): 67312509 |
Country: HK | Department of Health Drug Office | Identifier(s): 36207 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 8693 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1091300 |
Country: MT | Medicines Authority | Identifier(s): AA1123/02401 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 4858 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100062191, 100293281, 100293750, 100344297, 100426820, 100468196, 100468938 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W43693001 |
Country: SG | Health Sciences Authority | Identifier(s): 05209P |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 3153201H |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.